Showing results (21-30 of 173) with videos related to
Sort By:
Pageof 18
Current Opinion in Lipidology|September 27, 2024
Oral agents for lowering lipoprotein(a)Stephen J Nicholls, Adam J Nelson, Laura F MichaelProgress in Cardiovascular Diseases|July 14, 2019
Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetesAdam J Nelson, Eric D Peterson, Neha J PagidipatiAustralian Family Physician|November 6, 2017
Troponin testing in the primary care settingManuela S Mauro, Adam J Nelson, Michael B StokesExpert Review of Cardiovascular Therapy|March 24, 2022
Targeting triglycerides to lower residual cardiovascular riskKristen J Bubb, Adam J Nelson, Stephen J NichollsCurrent Opinion in Cardiology|September 26, 2023
Impact of PCSK9 inhibitors on coronary atheroma phenotype following myocardial infarction: insights from intravascular imagingTimothy Abrahams, Masashi Fujino, Adam J Nelson, et al.Expert Opinion on Pharmacotherapy|September 26, 2024
Evaluating obicetrapib as an emerging treatment for patients with dyslipidemia: a game changer?Stephen J Nicholls, Sean Tan, Julie Butters, et al.Journal of Cardiac Failure|October 10, 2024
Myocardial Revascularization in Heart Failure: A State-of-the-Art ReviewManasi Tannu, Adam J Nelson, Jennifer A Rymer, et al.The Journal of Heart Valve Disease|December 19, 2016
Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Basilar Artery Ischemic Stroke Following Transfemoral Transcatheter Aortic Valve ImplantationNicholas J Montarello, Adam J Nelson, Samuel L Sidharta, et al.Circulation Research|June 4, 2026
CETP Inhibitors: Back With a New TargetStephen J Nicholls, Kausik K Ray, Adam J Nelson, et al.Cancer Epidemiology|January 20, 2023
Cardiovascular risk factor reporting in immune checkpoint inhibitor trials: A systematic reviewSean Tan, Seiyon Sivakumar, Eva Segelov, et al.Pageof 18